Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma

By Lee Myung   Woo In   Kang Jin-Hyoung   Hong Young   Lee Kyung  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 6, 2004-06 ,pp. : 346-350

Springer Publishing Company

Access to resources Recommend Favorite

Epirubicin, Cisplatin and Infusional 5-Fluorouracil (5-FU) (ECF) in Hepatobiliary Tumours

By Ellis P.A.   Norman A.   Hill A.   O'Brien M.E.R.   Nicolson M.   Hickish T.   Cunningham D.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1594-1598

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

Randomised Phase II Study of Cisplatin and 5-Fluorouracil (5-FU) Versus Cisplatin Alone in Advanced Squamous Cell Oesophageal Cancer

By Bleiberg H.   Conroy T.   Paillot B.   Lacave A.J.   Blijham G.   Jacob J.H.   Bedenne L.   Namer M.   De Besi P.   Gay F.   Collette L.   Sahmoud T.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1216-1220

Elsevier

Access to resources Recommend Favorite

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite